Dergiler / Eurasian Journal of Medicine and Oncology / 2019 / Cilt: 3 - Sayı: 4

Plant Extracts in Hyperoxaluria Treatment: A Review of Experimental and Clinical Research

Sayfa
251–256
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Reducing hyperoxaluria is mainly caused by the ability of plants to inhibit nucleation and agglomeration of crystals by changing the ionic composition of urine and due to diuretic, nephroprotective, antioxidant and antibacterial effects.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This article is a review of the scientific literature.
📊
Temel Bulgular & Veri:We analysed the English language scientific literature Medline published from January 2008 to December 2018.
💡
Sonuç & Katkı:Reducing hyperoxaluria is mainly caused by the ability of plants to inhibit nucleation and agglomeration of crystals by changing the ionic composition of urine and due to diuretic, nephroprotective, antioxidant and antibacterial effects.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2008 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

This article is a review of the scientific literature. The purpose of this research was the systematization of the updated information on potential herbal medicine in hyperoxaluria treatment. We analysed the English language scientific literature Medline published from January 2008 to December 2018. Data in vitro, experimental and clinical studies demonstrated antiurolithiatic properties of many plant extracts. Reducing hyperoxaluria is mainly caused by the ability of plants to inhibit nucleation and agglomeration of crystals by changing the ionic composition of urine and due to diuretic, nephroprotective, antioxidant and antibacterial effects.

🔖

Bu Makaleye Atıf Yap

STEPANOVA, N. (2019). Plant Extracts in Hyperoxaluria Treatment: A Review of Experimental and Clinical Research. Eurasian Journal of Medicine and Oncology, Cilt: 3 - Sayı: 4, 251–256. https://ajindex.com/articles/125831

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol 2016
  2. 468–74. [CrossRef] 2. Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney Int 2011
  3. 1146–58. [CrossRef] 3. Knight J, Holmes RP, Assimos DG. Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res 2007
  4. 111–117. [CrossRef] 4. Marengo SR, Romani AM. Oxalate in renal stone disease: the terminal metabolite that just won't go away. Nat Clin Pract Nephrol 2008
  5. 368–77. [CrossRef] 5. Glew RH, Sun Y, Horowitz BL, Konstantinov KN, Barry M, Fair JR, et al. Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease. World J Nephrol 2014
  6. 122–42. [CrossRef] 6. Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria. Int J Nephrol 2011
  7. 864580. [CrossRef] 7. Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: Understanding the enigma. World J Nephrol 2015
  8. 235–244. [CrossRef] 8. Barnela SR, Soni SS, Saboo SS, Bhansali AS. Medical management of renal stone. Indian J Endocrinol Metab 2012
  9. 236– 239. [CrossRef] 9. Morgan Monica S C, Pearle Margaret S. Medical management of renal stones BMJ 2016
  10. i52. [CrossRef] 10. Azarfar A, Esmaeili M, Tousi N, Naseri M, Ghane F, Ravanshad Y, Alizadeh A. Evaluation of the effects of magnesium supplement in primary and secondary preventions of nephrolithiasis: a systematic review. Reviews in Clinical Medicine 2016
  11. 18–22. 11. Butterweck V, Khan SR. Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med 2009
  12. 1095–1103. [CrossRef] 12. Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms. Int J Mol Sci 2018
  13. Stepanova N. Lactobacillus probiotic decreases urinary oxalate excretion in non-stone formers women with recurrent pyelonephritis. Eur Urol Suppl 2016
  14. e1367. [CrossRef] 14. Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 2011
  15. G461–G469. [CrossRef] 15. Milliner D, Hoppe B, Groothoff J. A ran